Healthstream vs Genedx Holdings
Genedx Holdings is the larger business, with $428m of revenue in fiscal 2025 against $304m for Healthstream (1.4 times as much). Genedx Holdings grew faster (40.0% against 4.3%). Healthstream kept more of each dollar of sales as profit: a net margin of 6.0% against -4.9%.
| Latest fiscal year | HealthstreamHSTM, 2025 | Genedx HoldingsWGS, 2025 |
|---|---|---|
| Revenue | $304m | $428m |
| Revenue growth | 4.3% | 40.0% |
| Net income | $18.3m | −$21.0m |
| Operating margin | 6.7% | — |
| Net margin | 6.0% | -4.9% |
| Return on equity | 5.1% | -7.6% |
| Free cash flow | $59.6m | $14.3m |
| Cash | $36.2m | $105m |
| Total debt | $0 | $54.5m |
| Debt to equity | 0.0% | — |
| Dividend per share | $0.12 | — |
| Dividend yield | 0.4% | — |
| Share buybacks | $30.0m | — |
| Employees | — | — |
| Market value | $933m | $2.05bn |
| Price vs our value range | Below our value range | — |
| Moat score | 55 (Moderate) | 16 (Weak) |
| Insider trades, 12 months | 0 buys, 9 sales | 34 buys, 105 sales |